Lataa...
Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers
We assessed the efficacy of polaprezinc plus proton pump inhibitor (PPI) treatment for endoscopic submucosal dissection (ESD)-induced ulcer healing compared with rebamipide plus PPI treatment. BACKGROUND: ESD has been widely used as a local treatment option that cures gastric neoplasms. However, it...
Tallennettuna:
| Julkaisussa: | J Clin Gastroenterol |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Lippincott Williams & Wilkins
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7960146/ https://ncbi.nlm.nih.gov/pubmed/32341237 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCG.0000000000001357 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|